INTRODUCTION {#sec1}
============

In recent years, the increasing price and price volatility of poultry feed ingredients have led to more diets being formulated with high-fiber ingredients such as corn distillers' dried grains with solubles (**DDGS**), other cereal grains, milling by-products, and oilseed meals. These ingredients are more variable in their composition, and contain higher levels of non-starch polysaccharides (**NSP**), which reduce the digestibility of nutrients in the diets (Salim et al., [@bib37]) and can result in poorer growth and performance of birds (Annison and Choct, [@bib5]). Meanwhile, the use of sub-therapeutic antibiotics is restricted, both through regulatory action and consumer demand, in many geographies.

To address feed cost and variability, producers often turn to exogenous enzymes, including those targeted at the NSP fraction of the diet. Xylanase-supplemented birds have been shown to exhibit improved ileal digestibilities of nutrients and retention of components, with consequent improvements in apparent metabolizable energy (**AME~n~**) and growth performance (Kiarie et al., [@bib25]), effects that are evident in both wheat and corn based diets. Amylase targets the starch components of feed, improving starch digestibility via hydrolysis and releasing energy which can be utilized by the bird (Gracia et al., [@bib19]). Proteases are perhaps less well utilized in poultry production, and their mode of action in the gastrointestinal tract is less clear than for other enzymes (Adeola and Cowieson, [@bib2]). Nevertheless, research indicates that they can be effective in mediating the hydrolysis of proteins in the feed which both improves protein digestibility and reduces the presence of indigestible protein substrates for pathogenic bacteria in the gut. Evidence from a limited number of studies indicates that a combination of xylanase, amylase and protease can deliver greater improvements in outcomes such as AME~n~ (Romero et al., [@bib35], [@bib36]; Adebiyi and Olukosi, [@bib1]) nutrient utilization and solubilization of NSP in the gut (Olukosi et al., [@bib30]), than proteases or NSP-hydrolyzing enzymes given alone in corn- and/or wheat-based poultry diets.

As the use of antimicrobials is restricted globally, probiotics (also known as direct-fed microbials \[**DFMs**\]) can offer an additional means to positively influence the health and performance of poultry. Their mode of action is fundamentally different to that of enzyme supplements, altering the gut environment, modulating the activation of the immune system, and promote the colonization of beneficial microorganisms and inhibit colonisation of potential pathogens (Lee et al., [@bib26]). Recent studies of a commercial poultry probiotic based on 3 *Bacillus* strains have shown positive effects in terms of altered gut morphometry and reduced inflammatory markers (Lee et al., [@bib26]), as well as lower mortality, increased body weight, and improved production efficiency in commercial conditions in poultry fed corn-based diets (Dersjant-Li et al., [@bib14]).

Despite the frequency with which both NSP-hydrolyzing enzymes and probiotics are included in commercial poultry diets, little work to date has focused on the interaction between exogenous enzymes and probiotics in poultry diets---as enzymes are known to have a prebiotic effect in the broiler gut (Romero et al., [@bib35], [@bib36]), it is reasonable to hypothesize that their inclusion in broiler diets might lead to changes in gut microbial composition, enhancing or negating the effects of the probiotics, and thus influence health and performance to a greater degree than enzymes or probiotics alone. Therefore, the present study aimed to investigate the comparative effect of a commercially available *Bacillus*-based probiotic product, given alone or in combination with either of 2 multi-enzyme supplements, on growth performance, digestibility of nutrients and energy, disappearance of NSP, and gut microbial composition in broilers fed a commercially relevant corn-based diet.

MATERIALS AND METHODS {#sec2}
=====================

The experimental procedures were approved by the Animal Ethics Committee of Massey University, Palmerston North, New Zealand and the DuPont Agriculture and Animal Ethics Committee.

Exogenous Enzymes and Probiotics {#sec2-1}
--------------------------------

Two commercial multi-enzyme preparations were utilized: a combination of endo-1,4-β-xylanase (EC 3.2.1.8) originating from *Trichoderma reesei*, and α-amylase (EC 3.2.1.1) originating from *Bacillus licheniformis* (XA, Danisco Animal Nutrition, DuPont Industrial Biosciences, Marlborough, UK), formulated to provide 2,000 U/kg xylanase and 200 U/kg amylase, and; the same xylanase and amylase together with a serine protease (EC 3.4.21.62) originating from *Bacillus subtilis* (XAP, Danisco Animal Nutrition, DuPont Industrial Biosciences, Marlborough, UK), formulated to provide 2,000 U/kg feed xylanase, 200 U/kg amylase, and 4,000 U/kg protease. Enzyme activity levels in final feed samples (200 g) were measured at the DuPont Nutrition Biosciences Innovation Laboratories (Brabrand, Denmark) in duplicate, and reported as activity units. One xylanase unit is defined as the amount of enzyme that released 0.48 μmol of the reducing sugar xylose from wheat arabinoxylan per min at pH 4.2 and 50 °C. One amylase unit is defined as the amount of enzyme required to release, in the presence of excess α-glucosidase, 0.20 μmol of glucosidic linkages expressed as p-nitrophenol equivalents from a maltoheptaoside substrate per min at pH 8.0 and 40 °C. One protease unit is defined as the amount of enzyme that released 1.0 μg of phenolic compound, expressed as tyrosine equivalents, from a casein substrate per min at pH 7.5 and 40 °C.

The probiotic was a commercial preparation based on spores of a combination of 3 strains of *Bacillus amyloliquefaciens* (Danisco Animal Nutrition, DuPont Industrial Biosciences, Marlborough, UK). The probiotic was included in the diets at a rate of 1.5 × 10^5^ cfu/g of feed.

Experimental and Control Diets {#sec2-2}
------------------------------

2 basal diets based on corn and soybean meal, with added cDDGS and wheat middlings, were formulated to meet the recommended requirements for nutrients of the birds during the starter (d 1 to 21) and finisher (d 22 to 42) phases (NRC, [@bib29]; Table [1](#tbl1){ref-type="table"}). These diets represented the experimental Control (CTL) treatments. All diets contained 500 FTU/kg of a commercial *E. coli* phytase, expressed in *Trichoderma reesei* (Phyzyme XP, Danisco Animal Nutrition, Marlborough, UK). Titanium dioxide was added to the basal diets of birds used in Experiment 2 as an indigestible marker. Five further experimental diets were prepared from each of the control diets (starter and finisher), by addition of XA (CTL+XA), XAP (CTL+XAP), probiotic (CTL+DFM), probiotic and XA (CTL+DFM+XA), or probiotic and XAP (CTL+DFM+XAP). Diets were provided to birds ad libitum in mash form. All analyzed enzyme activities were within 20% of target doses, and *Bacillus* recovery was within 1 log cfu/g of target dose.

###### 

Ingredient and nutrient composition (% as fed) of the control (CTL) basal diets given in the starter (d 0--21) and finisher (d 21--42) phases.[^1^](#tb1fn1){ref-type="fn"}

                                                                Starter   Finisher
  ------------------------------------------------------------- --------- ----------
  **Ingredient, %**                                                       
  Corn                                                          46.22     46.73
  Wheat middlings                                               6.73      10.00
  Corn DDGS                                                     7.00      7.00
  Soybean meal (48% CP)                                         32.81     26.19
  Corn/Wheat Starch[^2^](#tb1fn2){ref-type="fn"}                0.30      0.30
  Animal/Vegetable fat                                          3.00      5.75
  L-Lysine HCL                                                  0.27      0.30
  DL-Methionine                                                 0.30      0.28
  L-Threonine                                                   0.11      0.12
  Titanium dioxide[^3^](#tb1fn3){ref-type="fn"}                 0.30      0.30
  Salt                                                          0.34      0.37
  Limestone                                                     1.12      1.14
  Dicalcium phosphate                                           1.20      1.22
  Poultry vitamin-mineral premix[^4^](#tb1fn4){ref-type="fn"}   0.30      0.30
  **Calculated Nutrient Composition, %**                                  
  ME, kcal/kg                                                   2952      3100
  Crude Protein                                                 23.00     20.40
  Digestible Lysine                                             1.21      1.07
  Digestible Methionine                                         0.62      0.57
  Digestible Methionine + Cysteine                              0.86      0.78
  Digestible Threonine                                          0.76      0.68
  Digestible Tryptophan                                         0.21      0.18
  Total P                                                       0.68      0.69
  Available P                                                   0.38      0.38
  Ca                                                            0.85      0.85
  Na                                                            0.18      0.19
  **Analyzed Nutrient Composition**                                       
  Dry Matter, %                                                 91.70     90.78
  Crude protein, % DM                                           24.95     22.60
  Crude fat, % DM                                               6.87      9.44
  Starch, % DM                                                  32.26     35.34
  GE, kcal/kg DM                                                4529.16   4746.65

^1^Both diets were top-dressed with phytase (Phyzyme XP, a 6-phytase from *E. coli*, expressed in *Trichoderma reesei* (Danisco Animal Nutrition, Marlborough, UK) to supply 500 FTU/kg feed.

^2^As a carrier for the enzyme and DFM premixes.

^3^Added to the diets used in Experiment 2 only (digestibility study), as an indigestible marker at the expense of corn.

^4^Supplied per kilogram of diet: antioxidant (ethoxyguin), 100 mg: biotin, 0.2 mg; calcium pantothenate, 12.8 mg; cholecalciferol, 60 μg; cyanocobalamin, 0.017 mg; folic acid, 5.2 mg; menadione, 4 mg; niacin 35 mg; pyridoxine, 10 mg; trans-retinol, 3.33 mg; riboflavin, 12 mg; thiamine, 3.0 mg; DL-α-tocopheryl acetate, 60 mg; choline chloride, 638 mg; Co, 0.3 mg; Cu, 3.0 mg; Fe, 25 mg; I, 1 mg; Mn, 125 mg; Mo, 0.5 mg; Se, 200 μg; Zn, 60 mg.

Animals, Housing, and Experimental Design {#sec2-3}
-----------------------------------------

One thousand and eighty Ross 308 male broiler chicks were obtained on day of hatch from a commercial hatchery, given a broiler coccidiosis vaccine (Immucox, Pacificvet, Christchurch, New Zealand) via drinking water, and assigned on the basis of body weight to floor pens (Experiment 1) or cohort cages (Experiment 2) so that pens and cages contained birds with approximately equal average bird weight.

In Experiment 1, a floor-pen trial to evaluate growth performance and gut microbiota composition was conducted. A total of 792 birds were allocated on d 1 to 36 pens with 22 birds/pen and 6 pens/dietary treatment in a random block arrangement. Pens were located in an environmentally controlled room where temperature was maintained at 32 ± 1 °C for the first 7 d and then gradually increased to 24 °C by d 21, under a 24 h fluorescent illumination cycle. Birds were given free access to diets and water. Body weight and feed intake (**FI**) were recorded on d 1, 21, 35, and 42. Mortality was recorded daily and used to correct calculations of feed conversion rate (**FCR**) at the end of the study (d 42). On d 11, 2 birds/pen (n = 72) birds were randomly selected, killed by cervical dislocation, and immediately dissected to obtain samples of ileal and cecal tissues. These were stored at −80 °C for subsequent microbial analysis by real-time polymerase chain reaction (**PCR**).

In Experiment 2, a cohort cage trial was conducted concurrently with the floor-pen trial to investigate the ileal digestibility of nutrients and energy resulting from the different dietary treatments, as well as their metabolizable energy content, and the ileal and total tract flow of sugar components of NSP. A total of 288 birds were allocated on d 1 to 36 cages with 8 birds/cage and 6 cages per dietary treatment in a random block arrangement. Cages were housed in an environmentally controlled room where temperature and light cycling conditions were identical to those in Experiment 1. Feed intake and total excreta output were measured quantitatively per cage on 4 consecutive days (d 17 to d 20) for the determination of AME and AME~n~ (via measurement of dry matter \[**DM**\], gross energy \[**GE**\], and nitrogen \[**N**\]). The daily excreta collections were pooled within a cage, mixed in a blender and sub-sampled. Each sub-sample was lyophilized, ground to pass through a 0.5 mm sieve and stored in airtight plastic containers at −4 °C pending analysis. On d 11 and 21, 4 birds per cage were euthanized by intracardial injection and the contents of the ileum expressed by gentle flushing with distilled water. Ileal digesta from birds within a cage were pooled, resulting in 6 samples per dietary treatment. Digesta samples were frozen immediately prior to analysis.

Chemical Analyses {#sec2-4}
-----------------

Ileal digesta samples collected on d 11 (Experiment 2) were analyzed for titanium (**Ti**), N, DM, and GE. Ileal digesta samples collected on d 21 (Experiment 2) were analyzed for Ti, N, DM, GE, starch, and fat, as well as NSP components and digestion resistant oligosaccharides. Excreta samples collected on d 17 to 20 (Experiment 2) were analyzed for DM, GE and N, in order to calculate AME and AME~n~, and additionally for NSP components and digestion resistant oligosaccharides. Digestion resistant oligosaccharides contain glycosidic bonds, often α(1,6)-linkages, which are less readily broken by intestinal enzymes, resulting in only partial digestion in the upper tract (Englyst et al., [@bib15]).

Titanium content was measured by a UV spectrophotometer according to the method of Short et al., ([@bib38]). Nitrogen content was determined by the combustion method (AOAC International, [@bib6], method 968.06) using a CNS-2000 carbon, nitrogen, and sulphur analyzer. DM content was determined using standard procedures (AOAC International, [@bib6]; method 930.15). GE was determined using an adiabatic bomb calorimeter (Gallenkamp Autobomb, London, UK) standardized with benzoic acid. Starch content was determined using the Megazyme Total Starch Assay Procedure (Megazyme International Ireland Ltd, Wicklow, Ireland) based on thermostable α-amylase and amyloglucosidase. Fat content was determined following the Soxhlet extraction procedure (AOAC International, [@bib6]; method 991.36). NSP components and digestion resistant oligosaccharides were analyzed using the methods of Englyst et al. ([@bib15]).

Calculations {#sec2-5}
------------

AME was calculated according to the following formula, in accordance with Ravindran et al., ([@bib32]): $$\documentclass[12pt]{minimal}
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\begin{eqnarray*}
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Total tract apparent retention of N was calculated according to the same formula by substitution of N~diet~ and N~excreta~ in place of the respective GE values. Appropriate corrections were made for differences in moisture content. AME~n~ was calculated by multiplication of AME with 8.22 kcal/g of N retention as described by Hill and Anderson ([@bib20]).

The apparent ileal digestibility (AID) of N, energy (AIDE), starch, and fat were calculated according to the following formula, based on the determined concentration of titanium in the diet and in the digesta, in accordance with Ravindran et al. ([@bib33]): $$\documentclass[12pt]{minimal}
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\end{document}$$where "nutrient" refers to either N, DM, starch, fat, or GE, (nutrient/Ti)~diet~ is the ratio of component and titanium in the experimental diet, and (nutrient/Ti)~ileal\ digesta~ is the ratio of component and titanium in ileal digesta.

Calculations of the flow of NSP components and of digestion resistant oligosaccharides were done using the concentrations of Ti and the respective NSP component in the diet as well as their concentrations in the ileal digesta (to determine ileal NSP/resistant oligosaccharide flow) or excreta (to determine total tract NSP/resistant oligosaccharide flow).

Real-Time PCR of Gut Microbiota {#sec2-6}
-------------------------------

Genomic DNA was isolated from 200 mg (wet weight) of ileal and cecal mucosa samples using a commercial kit (Bioline DNA Kit, Cat no. BIO-52,038). Extracted DNA was cleaned using a PowerClean Clean-up kit (Geneworks, Cat no. 12,877--50) and stored at −20 °C prior to PCR analysis.

Quantitative real-time PCR was performed with a Light Cycler (Roche Diagnostics, Risch-Rotkreuz, Switzerland) using SYBR Green I Master (Roche Diagnostics, Risch-Rotkreuz, Switzerland) after generation of standard curves for each of 7 bacterial species using an appropriate species specific primer set (Table [2](#tbl2){ref-type="table"}).

###### 

Oligonucleotide primers used for real-time PCR of ileal and cecal microflora composition.

  Bacteria                 Species used to generate standard curve      Primer         Primer Sequence                      Supporting reference
  ------------------------ -------------------------------------------- -------------- ------------------------------------ ---------------------------
  *E. coli*                *Escherichia coli*                           IEC-UPf        CAA TTT TCG TGT CCC CTT              Khan et al., [@bib23]
                                                                        IEC-DNr        GTT AAT GAT AGT GTG TCG AAA C        
  *Clostridium*            *Clostridium rhamnosus* CDC 8179             CJF            CTG AAT TGG ATA CCT TAA GTG CAG C    Skanseng et al., [@bib39]
                                                                        CJR            AGG CAC GCC TAA ACC TAT              
  *Campylobacter spp.*     *Campylobacter jejuni* CCUG 11,284           R-campF2       CAC GTG CTA CAA TGG CAT AT           Lund et al., [@bib27]
                                                                        R-campR2       GGC TTC ATG CTC TCG AGT T            
  *Bifidobacterium spp.*   *Bifidobacterium breve* ATCC 15,700          Bif1-F         TCG CGT CYG GTG TGA AAG (Y = CT)     Rinttila et al., [@bib34]
                                                                        Bif2-R         CCA CAT CCA GCR TCC AC (R = Ag)      
  *Bacteroides spp.*       *Bacteroides thetaiotaomicron* ATCC 29,148   Allbac296F     GAG AGG AGG GTC CCC CA               Bernhard & Field, [@bib9]
                                                                        Allbac412R     CGC TAC TTG GCT GGT TCA              
  *Lactobacillus spp.*     *Lactobacillus acidophilus* ATCC 11,975      Lab-0159-F     GGA AAC AGR TGC TAA TAC CG           Collier et al., [@bib12]
                                                                        UnivL-0515-R   ATC GTA TTA CCG CGG CTG CTG GCA      
  *Salmonella Spp.*        *Salmonella typhimurium ATCC 14,028*         Sal-invA1-F    GTG AAA TTA TCG CCA CGT TCG GGC AA   Rahn et al., [@bib31]
                                                                        Sal-invA2-R    TCA TCG CAC CGT CAA AGG ACC C        Eyigor et al., [@bib16]

The composition of reaction mix per sample was: 3 μL PCR water, 1 μL of each primer (0.5 μM), 5 μL template DNA and 10 μL of SYBR Green I Master. The PCR program consisted of an initial denaturation and anti-Taq DNA polymerase antibody-inactivation step for 10 min at 95 °C, an amplification step (45 cycles of 15 s at 95 °C, 60 s at 63 °C and 10 s at 72 °C) and a melting-curve determination step (95 °C for 5 s, 65 °C for 60 S, 97 °C with continuous hold). Measurement of SYBR green fluorescence was performed at the end of each amplification step and continuously during the melt-curve-analysis.

For generation of each standard curve, a 10-fold dilution of an overnight grown culture was prepared in a particle-free sterile saline solution, after which triplicate 50 μL aliquots of each dilution were spread-plated on specific medium. Colonies were counted after 72 h of anaerobic incubation at 37 °C for anaerobes and overnight incubation for aerobes. Standard curves were generated in the range of 101 to 1010 bacterial cell numbers per mL from real-time PCR analysis of DNA extracted from the initial dilution series using 16SrRNA, with samples analyzed in duplicate. As a standard calibration point, each run included one DNA sample from the dilution series originally used to create the standard curve.

Results were reported as equivalent log 10 cfu per DNA concentration.

Statistical Analysis {#sec2-7}
--------------------

Data on growth performance, digestibility of nutrients and energy, and flow of NSP components and digestion resistant oligosaccharides were based on a pen basis; data on microflora composition were based on individual birds. Data were analyzed by analysis of variance (ANOVA) using the Fit Model platform of JMP 11.0 (SAS Institute Inc., Cary, NC, 1989--2013) to investigate the effects of treatments, with dietary treatment included as a fixed effect. Means separation was achieved using Tukey\'s Honest Standard Difference test. Differences were considered significant at *P* \< 0.05; *P* \< 0.01 was considered a trend.

RESULTS {#sec3}
=======

The influence of the multi-enzyme and probiotic combinations on broiler growth performance are given in Table [3](#tbl3){ref-type="table"}. Bodyweight gain (**BWG**) was increased in birds fed the probiotic alone (**DFM**) compared with those fed the control diet, both in the starter phase (d 1 to 21) (953.19 vs. 889.13 g/d; *P \<* 0.05) and overall (d 1 to 42) (3,276.32 vs. 3,129.27 g/d; *P \<* 0.05). There was no significant effect of XA or XAP on BWG, but XAP significantly improved BWG and final BW overall compared with control birds (BWG 3,285.98 vs. 3,129.27 g/d, Final BW 3,323.48 vs. 3,166.54 g; *P* \< 0.05). Effects on FI were similar to those seen for BWG: in comparison with control birds, birds fed the probiotic exhibited increased FI at all 3 time points (*P* \< 0.05), XA had no effect on FI, while XAP increased FI in the finisher period only (*P* \< 0.05). Neither DFM+XA nor DFM+XAP affected BWG or FI significantly compared to control birds. No significant effects on FCR were observed for any of the dietary treatments.

###### 

Effect of multi-enzyme combinations XA (xylanase, amylase) and XAP (xylanase, amylase, and protease), and their combination with a *Bacillus* probiotic (DFM) on broiler growth performance (Experiment 1).

                                      Control                                                     NC + DFM       NC + DFM               
  ----------------------------------- -------------- -------------- -------------- -------------- -------------- -------------- ------- -------
  **Starter Phase, d 1--21**                                                                                                            
  BW gain (g/bird)                    889.13^b^      880.42^b^      907.44^a,b^    953.19^a^      903.08^a,b^    928.62^a,b^    14.49   0.015
  Feed intake (g/bird)                1141.01^a,b^   1110.85^b^     1141.63^a,b^   1209.65^a^     1149.92^a,b^   1169.53^a,b^   17.81   0.013
  FCR                                 1.28           1.26           1.26           1.27           1.27           1.26           0.01    0.535
  **Finisher Phase, d 22--42**                                                                                                          
  BW gain (g/bird)                    2240.13        2316.744       2378.54        2323.12        2326.33        2328.65        30.30   0.085
  Feed intake (g/bird)                3820.83^b^     3923.83^a,b^   3987.97^a^     3980.73^a^     3897.82^a,b^   3941.91^a,b^   34.71   0.021
  FCR                                 1.71           1.70           1.68           1.72           1.68           1.70           0.02    0.828
  **Overall, d 1 - 42**                                                                                                                 
  Final BW (g/bird)                   3166.54^b^     3234.61^a,b^   3323.48^a^     3313.78^a,b^   3266.83^a,b^   3294.73^a,b^   32.17   0.016
  BW gain (g/bird)                    3129.27^b^     3197.15^a,b^   3285.98^a^     3276.32^a^     3229.41^a,b^   3257.27^a,b^   32.18   0.017
  Feed intake (g/bird)                4961.84^b^     5034.68^a,b^   5129.60^a,b^   5190.38^a^     5047.74^a,b^   5111.44^a,b^   46.45   0.025
  FCRc[^4^](#tb3fn5){ref-type="fn"}   1.64           1.62           1.60           1.62           1.60           1.60           0.01    0.132

^a--c^Means in the same row with no common superscripts are significantly different (*P* \< 0.05)

^1^Supplied at a dose level which provided 2,000 units of xylanase per kg feed and 200 units of amylase per kg feed.

^2^Supplied at a dose level which provided 2,000 units of xylanase per kg feed, 200 units of amylase per kg feed, and 4000 units of protease per kg feed.

^3^Supplied at a dose level which provided 150,000 cfu/g of feed.

^4^Corrected for mortality

None of the multi-enzyme/probiotic dietary treatment combinations gave rise to improvements in the AID of nitrogen (Table [4](#tbl4){ref-type="table"}). However, there were significant improvements in all other variables: AIDE was increased among birds fed either XA or XAP in combination with the probiotic, compared with control fed birds, at both time-points (AIDE on d 21 74.15% (DFM+XAP) vs. 70.48% (NC)) (*P* \< 0.05). Although numerically higher, effects of the enzymes or probiotic given alone on AIDE were not significant. The size of the observed effects of the combined treatments (DFM+XA or DFM+XAP) on AIDE on d 21 were greater than the sum of the effect of the individual additives when given alone (by 0.33% in the DFM+XA group and by 1.27% (∼58 kcal) in DFM+XAP birds). Improvements were also seen in AIDE on d 11, and to an even greater extent on d 21 with DFM+XA and DFM+XAP compared with the CTL group (3,318 kcal/kg DM (DFM+XA) or 3,358 kcal/kg DM (DFM+XAP) vs. 3,192 kcal/kg (NC)) (*P* \< 0.01), but again these effects were not evident when the enzymes/probiotics were given alone. AID of fat on d 21 was increased by addition of XA and XAP, but not the probiotic, compared with the CTL group (88.81 vs. 86.24% and 89.87% vs. 86.24% respectively) (*P* \< 0.01), and AID of starch was increased by all 3 of these treatments (XA, XAP, or DFM) (*P* \< 0.001). Combining the enzymes and the probiotic together produced a similar positive effect on AID of fat and starch to that produced by the supplements given individually (*P* \< 0.01). Figure [1](#fig1){ref-type="fig"} displays the relative improvements in the digestibility of protein (nitrogen), fat, starch, and energy in the enzyme and/or probiotic supplemented diets compared with the control diet, and the marked increase in AIDE in DFM+XAP supplemented birds is very apparent. AME~n~ was increased by XAP but not XA, compared with CTL birds (3,042 vs. 2,960 kcal) (*P* \< 0.001), and was improved even more by DFM+XA and DFM+XAP (3,074 DFM+XA vs. 2,960 kcal CTL and 3,092 DFM+XAP vs. 2,960 kcal CTL respectively) (*P* \< 0.001).

![Improvements in the ileal digestibility of protein (nitrogen), fat, starch and energy (IDE) in broilers fed a corn-soybean based diet supplemented with enzymes (XA/XAP), a *Bacillus* probiotic (DFM), or both together, on d 21. Improvements in IDE are given by the black bars---the difference between the contributions of protein, fat and starch and overall IDE in the DFM+XA and DFM+XAP groups is hypothesized to be due to increased energy release from fiber.](pex226fig1){#fig1}

###### 

Effect of multi-enzyme combinations XA (xylanase, amylase) and XAP (xylanase, amylase, and protease), given with and without a *Bacillus* probiotic (DFM) on Ileal digestibility of nutrients and energy, nitrogen retention and metabolizable energy content in broilers (Experiment 2).

                                                               Control                                               NC + DFM      NC + DFM             
  ------------------------------------------------------------ ----------- ------------- ------------- ------------- ------------- ------------ ------- -------
  **Starter Phase, d 1--21**                                                                                                                            
  Ileal digestibility of N (%)                                 83.47       85.11         84.79         84.04         84.72         84.45        0.63    0.497
  Ileal digestibility of GE[^4^](#tb4fn5){ref-type="fn"} (%)   68.20^b^    71.66^a,b^    72.16^a,b^    70.35^a,b^    72.58^a^      72.58^a^     0.96    0.020
  AIDE[^5^](#tb4fn6){ref-type="fn"} (kcal/kg DM)               3089.0^b^   3246.0^a,b^   3268.0^a,b^   3186.0^a,b^   3287.0^a^     3287.0^a^    43.51   0.020
  **Finisher Phase, d 22--42**                                                                                                                          
  Ileal digestibility of N (%)                                 83.31       84.08         84.08         84.07         84.61         85.13        0.75    0.649
  Ileal digestibility of Fat (%)                               86.24^c^    88.81^a,b^    89.87^a^      87.31^b,c^    89.00^a,b^    89.94^a^     0.53    0.002
  Ileal digestibility of Starch (%)                            92.74^c^    97.29^a^      97.53^a^      95.50^b^      97.53^a^      97.79^a^     0.23    0.001
  Ileal digestibility of GE (%)                                70.48^c^    72.16^a-c^    72.12^a-c^    71.24^b,c^    73.25^a,b^    74.15^a^     0.61    0.001
  AIDE (kcal/kg/DM)                                            3192.0^c^   3268.0^a-c^   3266.0^a-c^   3226.0^b,c^   3318.0^a,b^   3358.0^a^    27.40   0.002
  Retention of N (%)                                           68.89^b^    70.57^a,b^    70.75^a,b^    69.06^b^      71.66^a^      70.95^a,b^   0.53    0.005
  AME~n~ (Kcal)                                                2960.0^c^   3016.0^a-c^   3042.0^a,b^   2995.0^b,c^   3074.0^a^     3092.0^a^    16.76   0.001
                                                                                                                                                        

^a--c^Means in the same row with no common superscripts are significantly different (*P* \< 0.05)

^1^Supplied at a dose level that provided 2,000 units of xylanase per kg feed and 200 units of amylase per kg feed.

^2^Supplied at a dose level that provided 2,000 units of xylanase per kg feed, 200 units of amylase per kg feed, and 4,000 units of protease per kg feed.

^3^Supplied at a dose level that provided 150,000 cfu/g of feed.

^4^GE- Gross Energy

^5^AIDE---Apparent ileal digestible energy

###### 

Ileal flow (g/100 g DM intake) of components of non-starch polysaccharides in response to feeding diets supplemented with enzyme combinations XA (xylanase, amylase) and XAP (xylanase, amylase, and protease), with and without a *Bacillus* probiotic (DFM), in broilers (Experiment 2).

                                  Control                                       NC + DFM    NC + DFM           
  ------------------- ----------- --------- ----------- ----------- ----------- ----------- ----------- ------ -------
  Rhabinose           Soluble     0.04      0.03        0.03        0.05        0.02        0.03        0.01   0.826
                      Insoluble   0.07      0.06        0.06        0.06        0.06        0.05        0.01   0.861
                      Total       0.11      0.09        0.09        0.10        0.08        0.08        0.02   0.889
  Fructose            Soluble     0.09      0.07        0.08        0.08        0.07        0.08        0.01   0.811
                      Insoluble   0.04      0.05        0.03        0.04        0.04        0.04        0.01   0.559
                      Total       0.13      0.12        0.12        0.12        0.11        0.12        0.01   0.940
  Arabinose           Soluble     0.38      0.36        0.32        0.32        0.33        0.34        0.04   0.855
                      Insoluble   1.90^a^   1.77^a,b^   1.83^a,b^   1.91^a^     1.74^b^     1.69^b^     0.05   0.024
                      Total       2.29      2.13        2.15        2.23        2.08        2.03        0.06   0.057
  Xylose              Soluble     0.29      0.22        0.25        0.22        0.20        0.22        0.04   0.773
                      Insoluble   2.35      2.23        2.21        2.37        2.19        2.09        0.07   0.091
                      Total       2.64      2.45        2.45        2.59        2.39        2.31        0.08   0.068
  Mannose             Soluble     0.14      0.14        0.12        0.14        0.12        0.11        0.01   0.375
                      Insoluble   0.15      0.14        0.16        0.16        0.15        0.15        0.02   0.980
                      Total       0.29      0.29        0.29        0.30        0.27        0.26        0.02   0.874
  Galactose           Soluble     0.59      0.58        0.56        0.55        0.57        0.53        0.04   0.890
                      Insoluble   0.98^a^   0.86^a,b^   0.91^a,b^   0.99^a^     0.84^b^     0.86^a,b^   0.03   0.007
                      Total       1.56^a^   1.45^a,b^   1.48^a,b^   1.54^a^     1.41^b^     1.39^b^     0.04   0.035
  Glucose             Soluble     0.23      0.25        0.17        0.14        0.19        0.22        0.04   0.485
                      Insoluble   2.61      2.44        2.53        2.60        2.42        2.34        0.07   0.083
                      Total       2.84      2.69        2.70        2.75        2.62        2.56        0.08   0.271
  Galacturonic Acid   Soluble     0.49      0.45        0.48        0.47        0.48        0.48        0.06   0.999
                      Insoluble   0.45      0.42        0.44        0.45        0.39        0.38        0.04   0.766
                      Total       0.94      0.87        0.92        0.92        0.87        0.86        0.05   0.805
  Total               Soluble     2.02^a^   1.76^a,b^   1.71^a,b^   1.85^a,b^   1.58^a,b^   1.56^b^     0.10   0.041
                      Insoluble   8.56^a^   7.99^a,b^   8.12^a,b^   8.57^a^     7.83^a,b^   7.59^b^     0.22   0.016
                      Total       10.79     10.09       10.20       10.54       9.82        9.61        0.29   0.077

^a,b^Means in the same row with no common superscripts are significantly different (*P* \< 0.05)

^1^Supplied at a dose level that provided 2,000 units of xylanase per kg feed and 200 units of amylase per kg feed.

^2^Supplied at a dose level that provided 2,000 units of xylanase per kg feed, 200 units of amylase per kg feed, and 4,000 units of protease per kg feed.

^3^Supplied at a dose level that provided 150,000 cfu/g of feed.

The ileal flow of NSP components in response to the dietary treatments is shown in Table [5](#tbl5){ref-type="table"}. Administration of either XA, XAP or the probiotic alone did not affect ileal flow of NSP. Both DFM+XA and DFM+XAP reduced the ileal flow of insoluble arabinose (*P* \< 0.05) relative to the CTL group. DFM+XAP additionally reduced the ileal flow of total galactose, and DFM+XA reduced ileal flow of both total galactose and insoluble galactose (*P* \< 0.01) compared with CTL birds. Effects of the treatments on total tract flow of NSP (Table [6](#tbl6){ref-type="table"}) were greater in magnitude, but otherwise generally mirrored effects on ileal flow of NSP, with the DFM+XAP treatment producing the most significant effects among the treatments, in both magnitude and number of NSP components affected. Total tract flow of total and insoluble arabinose, as well as total galactose, were reduced by DFM+XAP compared with the CTL group (*P* \< 0.001, *P* \< 0.01, and *P \<* 0.01 respectively). In contrast, DFM+XA only significantly reduced the flow of total arabinose (*P* \< 0.001). DFM+XAP additionally produced a reduction in the flow of soluble, insoluble and total xylose at the total tract level, compared with the CTL group (*P* \< 0.05, *P* \< 0.001, *P* \< 0.001). This effect was not produced by DFM+XA.

###### 

Total tract flow (g/100 g DM intake) of components of non-starch polysaccharides in response to feeding diets supplemented with enzyme combinations XA (xylanase, amylase) and XAP (xylanase, amylase, and protease), with and without a *Bacillus* probiotic (DFM), in broilers (Experiment 2).

                                  Control                                           NC + DFM    NC + DFM          
  ------------------- ----------- ------------ ------------ ----------- ----------- ----------- ---------- ------ -------
  Rhabinose           Soluble     0.03         0.02         0.03        0.03        0.03        0.03       0.01   0.960
                      Insoluble   0.06         0.07         0.07        0.06        0.06        0.05       0.01   0.451
                      Total       0.09         0.09         0.10        0.09        0.09        0.08       0.01   0.522
  Fructose            Soluble     0.06         0.06         0.06        0.07        0.05        0.06       0.01   0.653
                      Insoluble   0.04         0.03         0.02        0.03        0.04        0.03       0.01   0.560
                      Total       0.10         0.09         0.08        0.10        0.09        0.09       0.01   0.138
  Arabinose           Soluble     0.27         0.26         0.26        0.29        0.19        0.23       0.03   0.167
                      Insoluble   2.05^a^      1.92^a,b^    1.91^a,b^   2.03^a^     1.90^a,b^   1.82^b^    0.04   0.001
                      Total       2.32^a^      2.17^a,b^    2.17^a,b^   2.32^a^     2.09^b^     2.05^b^    0.04   0.001
  Xylose              Soluble     0.24^a^      0.15^b^      0.17^b^     0.20^a,b^   0.15^b^     0.16^b^    0.02   0.039
                      Insoluble   2.51^a,b^    2.37^b,c^    2.36^b,c^   2.55^a^     2.38^b,c^   2.28^c^    0.04   0.001
                      Total       2.76^a^      2.52^b^      2.54^b^     2.75^a^     2.52^b^     2.44^b^    0.04   0.001
  Mannose             Soluble     0.11         0.13         0.12        0.12        0.11        0.13       0.01   0.788
                      Insoluble   0.22         0.21         0.21        0.22        0.19        0.20       0.01   0.190
                      Total       0.34         0.34         0.33        0.34        0.30        0.33       0.01   0.165
  Galactose           Soluble     0.48         0.49         0.47        0.48        0.42        0.43       0.03   0.325
                      Insoluble   1.09         1.01         1.01        1.12        1.02        1.00       0.03   0.084
                      Total       1.57^a,b^    1.50^a-c^    1.48^a-c^   1.61^a^     1.44^b,c^   1.42^c^    0.03   0.002
  Glucose             Soluble     0.29         0.13         0.15        0.16        0.15        0.13       0.04   0.089
                      Insoluble   2.62         2.66         2.60        2.79        2.62        2.59       0.06   0.228
                      Total       2.92         2.79         2.75        2.95        2.77        2.72       0.06   0.040
  Galacturonic Acid   Soluble     0.52         0.52         0.45        0.49        0.48        0.41       0.04   0.368
                      Insoluble   0.40         0.41         0.42        0.44        0.39        0.39       0.02   0.452
                      Total       0.92         0.93         0.88        0.93        0.86        0.80       0.03   0.040
  Total               Soluble     2.02^a^      1.76^a,b^    1.71^a,b^   1.84^a,b^   1.58^a,b^   1.56^b^    0.10   0.041
                      Insoluble   8.99^a,b^    8.68^b,c^    8.61^b,c^   9.24^a^     8.59^b,c^   8.37^c^    0.12   0.001
                      Total       11.01^a,b^   10.43^b,c^   10.32^c^    11.08^a^    10.17^c^    9.93^c^    0.15   0.001

^a--c^Means in the same row with no common superscripts are significantly different (*P* \< 0.05)

^1^Supplied at a dose level that provided 2,000 units of xylanase per kg feed and 200 units of amylase per kg feed.

^2^Supplied at a dose level that provided 2,000 units of xylanase per kg feed, 200 units of amylase per kg feed, and 4,000 units of protease per kg feed.

^3^Supplied at a dose level that provided 150,000 cfu/g of feed.

###### 

Ileal and total tract flow of digestion resistant oligosaccharides and starch (g/100 g DM intake) in response to feeding diets supplemented with enzyme combinations XA (xylanase, amylase) and XAP (xylanase, amylase, and protease), with and without a *Bacillus* probiotic (DFM), in broilers (Experiment 2).

                         Control                                       NC + DFM    NC + DFM           
  ---------------------- --------- ----------- ----------- ----------- ----------- ----------- ------ -------
  **Ileal flow**                                                                                      
  Fructose               0.61^a^   0.50^a,b^   0.46^b^     0.58^a,b^   0.51^a,b^   0.52^a,b^   0.03   0.007
  Galactose              0.78      0.65        0.67        0.75        0.69        0.67        0.04   0.072
  Glucose                0.41      0.33        0.37        0.38        0.36        0.34        0.02   0.249
  Total NSP              1.80^a^   1.48^b^     1.52^a,b^   1.72^a,b^   1.58^a,b^   1.52^a,b^   0.07   0.024
  Total Starch           1.37      1.26        1.23        1.48        1.46        1.18        0.09   0.140
  **Total Tract Flow**                                                                                
  Fructose               0.15      0.18        0.17        0.18        0.21        0.15        0.02   0.502
  Galactose              0.19      0.22        0.17        0.23        0.23        0.18        0.03   0.456
  Glucose                0.10      0.11        0.10        0.11        0.13        0.10        0.01   0.617
  Total NSP              0.44      0.51        0.43        0.52        0.55        0.42        0.06   0.542
  Total Starch           1.46      1.30        1.30        1.20        1.43        1.30        0.10   0.514

^a,b^Means in the same row with no common superscripts are significantly different (*P* \< 0.05)

^1^Supplied at a dose level which provided 2,000 units of xylanase per kg feed and 200 units of amylase per kg feed.

^2^Supplied at a dose level which provided 2,000 units of xylanase per kg feed, 200 units of amylase per kg feed, and 4,000 units of protease per kg feed.

^3^Supplied at a dose level which provided 150,000 cfu/g of feed.

The flow of total digestion resistant oligosaccharides (ROs) in the ileal tract was numerically lower among all treatments compared with the CTL group (Table [7](#tbl7){ref-type="table"}), but this was only significant in XA fed birds (*P* \< 0.05). Ileal flow of resistant fructose was reduced in the XAP treatment group compared with the CTL group (*P* \< 0.01), but no other significant reductions in flow were detected among individual ROs at the ileal level. At the total tract level, no significant differences in total or individual flow of ROs were detected.

No differences in bacterial species levels in the ileum were apparent among the different treatment groups (Table [8](#tbl8){ref-type="table"}). However, *Bacteroides* and *Campylobacter* species levels were both reduced in the cecum in the XA and XAP treatment groups compared with the CTL group (*P* \< 0.05 and *P* \< 0.001 respectively). The magnitude of the effect of XA and XAP on *Bacteroides* levels was relatively small (5.20 (XA) or 5.25 (XAP) vs. 5.58 log cfu/g (NC), *P* = 0.028) but effects on the levels of *Campylobacter* species were greater than 2.5 log cfu/g in both cases (3.43 (XA) or 2.54 (XAP) vs. 5.25 log cfu/g (NC), *P* \< 0.001). Statistically significant effects were not detected among these species when the enzymes were combined with the probiotic, with the exception of DFM+XAP which produced a \<1 log reduction in *Campylobacter* species levels compared with the CTL group (*P* \< 0.001). There were no effects of the probiotic alone on levels of any of the species of bacteria studied in the ileum or cecum.

###### 

Effect of dietary supplementation with enzyme combinations XA (xylanase, amylase) and XAP (xylanase, amylase, and protease), with and without a *Bacillus* probiotic (DFM), on ileal and cecal microflora composition (log cfu/g of wet digesta) of broilers on d 11 as determined by RT-PCR (Experiment 1).

                     Control                                     NC + DFM    NC + DFM           
  ------------------ --------- ----------- --------- ----------- ----------- ----------- ------ -------
  **Ileum**                                                                                     
  *Bacteroides*      5.98      6.12        6.08      6.07        5.84        6.01        0.07   0.054
  *Bifidobacteria*   9.32      9.46        9.49      9.38        9.36        9.31        0.08   0.481
  *Campylobacter*    5.86      5.98        5.34      5.82        4.13        5.64        0.58   0.222
  *Clostridium*      4.08      4.81        4.73      3.99        3.96        4.02        0.31   0.174
  *E. Coli*          3.28      3.88        4.31      4.14        4.41        3.91        0.32   0.152
  *Lactobacillus*    9.61      9.69        9.62      9.53        9.21        9.46        0.16   0.363
  *Salmonella*       3.87      3.83        4.02      4.07        4.10        4.10        0.10   0.252
  **Cecum**                                                                                     
  *Bacteroides*      5.58^a^   5.20^b^     5.25^b^   5.58^a^     5.57^a^     5.46^a,b^   0.11   0.028
  *Bifidobacteria*   9.16      9.08        9.05      9.13        9.15        9.14        0.07   0.860
  *Campylobacter*    5.25^a^   3.43^b,c^   2.54^c^   5.07^a,b^   4.72^a,b^   4.04^b,c^   0.42   0.001
  *Clostridium*      7.04      6.78        6.72      7.05        7.00        6.75        0.11   0.074
  *E. Coli*          6.84      6.79        7.03      6.49        6.56        6.26        0.70   0.978
  *Lactobacillus*    9.58      9.54        9.35      9.58        9.60        9.66        0.20   0.921
  *Salmonella*       3.63      4.28        3.38      3.91        3.25        3.53        0.33   0.269

^a--c^Means in the same row with no common superscripts are significantly different (*P* \< 0.05)

^1^Supplied at a dose level that provided 2,000 units of xylanase per kg feed and 200 units of amylase per kg feed.

^2^Supplied at a dose level that provided 2,000 units of xylanase per kg feed, 200 units of amylase per kg feed, and 4,000 units of protease per kg feed.

^3^Supplied at a dose level that provided 150,000 cfu/g of feed.

DISCUSSION {#sec4}
==========

The inclusion of wheat middlings and corn-DDGS in grain-soybean meal poultry diets reduces their nutrient and energy digestibility (Jaroni et al., [@bib22]; Salim et al., [@bib37]). The major mechanism for this effect is thought to be associated with increased viscosity in the gut, mediated by higher levels of major NSP such as arabinoxylans and pentosans (Annison and Choct, [@bib5]; Bedford and Schulze, [@bib8]). These may reduce nutrient digestion in the small intestine via inhibition of the proper mixing of dietary components (Ward, [@bib40]) and decreased flow-rate of metabolites along the gut (Fengler and Marquardt, [@bib17]), leading to decreased absorption of nutrients. Increased viscosity may also alter the delicate balance of microflora in the gut, which may further impair digestion and absorption. The present study showed significant benefits of XA supplementation in terms of an improvement in the ileal digestibility of starch and of fat on d 22 to 42 compared to the control. Supplementation with XAP gave rise to similar improvements but, in addition, a significant improvement (of, on average, 82 kcal) in AME~n~. These findings are in broad agreement with those of Romero et al. ([@bib35], [@bib36]), in which similar benefits of XA and XAP supplementation on AID of starch and of fat were observed. In addition, these authors reported a clear additional benefit of XAP over XA in terms of increased AID of nitrogen/protein and AA, and a greater increase in AID of energy and in AME~n~ (Romero et al., [@bib35], [@bib36]). Olukosi et al. ([@bib30]) reported an improvement in AME in broilers fed a corn-based diet supplemented with protease. Similarly, the increased AME~n~ that we observed in the XAP supplemented group compared with the CTL group, which was absent in the XA treated group, suggests that the protease in the XAP may have resulted in beneficial effects in nutrient and energy utilization that were to some degree independent of protein digestion.

The combination of *Bacillus* probiotics and exogenous enzymes led to additional and more significant effects on the apparent ileal digestibility of nutrients and energy than their delivery alone. In particular, the magnitude of the improvements in AIDE and in AME~n~ in the DFM+XA and DFM+XAP treatments, when compared with treatments involving enzymes given alone and with the control diet, were suggestive of a beneficial interaction occurring between the probiotic and XA/XAP. The precise mechanisms for the interaction between enzymes and probiotic are as yet unclear. However, research indicates that these enzymes, in particular xylanases, can have a "prebiotic" effect in the poultry gut, via a combination of increasing the availability of substrates for beneficial bacteria due to their hydrolyzing effects on NSP, starch and protein (Bedford and Cowieson, [@bib7]; Romero et al., [@bib35], [@bib36]), and a reduction in indigestible protein and other substrates that favor the growth of pathogenic bacteria (Kiarie et al., [@bib24]). XA and XAP supplementation, therefore, may have altered the substrates available to the probiotic *Bacillus* strains in the gut, resulting in more magnified effects on nutrient and energy utilization than were achieved by the probiotic or enzymes given alone.

The efficiency of digestion of starch, fat or protein in broiler diets is not necessarily comparable with that of NSP component sugars (Chwalibog, [@bib11]). Therefore, it is potentially also helpful to look at the degree of NSP hydrolysis, potentially providing additional clues as to the contributing factors responsible for observed improvements in digestibility of energy and nutrients. It is expected that a greater degree of hydrolysis of NSP will result in a reduced level of NSP components being detectable in the DM. In the present study, combined supplementation of the enzymes (XA or XAP) with the probiotic led to reductions in the flow of insoluble arabinose (and galactose in the XA group) compared with control fed birds, and these effects were apparent at both the ileal and total tract levels. The latter also showed a reduction in both soluble and insoluble fractions of xylose in the DFM+XAP supplementation group. This is broadly in line with previous studies, in particular Olukosi et al. ([@bib30]), who also reported a reduction in ileal flow of insoluble arabinose and in the post-cecal flow of insoluble xylose in XAP supplemented broilers on similar corn-based diets. Arabinose and xylose are important components of hemicellulose in corn and corn-DDGS, and the current results are indicative of an increase in the hydrolysis of arabinoxylan polymers in the small intestine of birds supplemented with DFM+XAP. These findings further suggest that DFM+XAP may deliver a greater benefit than DFM+XA in terms of reducing the flow of component NSP, particularly insoluble arabinose and xylose. As hypothesised by Olukosi et al. ([@bib30]), it is plausible that the joint actions of NSP-hydrolyzing enzymes and proteases disrupt the cell wall fiber-protein matrix, and thus may be responsible for the apparently greater effect of DFM+XAP compared with DFM+XA on NSP flow in our study.

The major ROs in corn-soybean meal based diets are raffinose and stachyose (Honig and Rakies, [@bib21]), which make up 4 to 6% of the total oligosaccharides; β-mannans are also present in soybean meal to a lesser extent. These fermentable fibers have been ascribed both positive (Anderson et al., [@bib4]) and negative (Coon et al., [@bib13]) effects on various digestion and immunological related response measures associated with gut health in poultry. In a previous study, Olukosi et al. ([@bib30]) observed significant reductions in the post-cecal flow of glucose and galactose from the RO fraction in XAP supplemented broilers. In the present study, there were no effects on the flow of ROs at the total tract level. In the ileum, the responses were somewhat inconsistent, whereby flow of resistant fructose was reduced in XAP but not in DFM+XAP supplemented birds.

These changes in NSP flow through the gut are likely to be one of the primary mechanisms behind the observed reductions (\>2.5 log) in *Campylobacter* presence in the ceca of birds supplemented with XA, XAP and DFM+XAP: the hydrolytic actions of the enzymes on the fiber-protein components of the feed may have reduced the levels of undigested materials which would otherwise form substrates for bacteria such as *Campylobacter*, thereby reducing their apparent levels in the cecum when compared with control fed birds, though this warrants further investigation. The effect of the NSP-hydrolyzing enzymes on *Campylobacter* is likely unrelated to the observed reductions in *Bacteroides* levels as the colonisation patterns of these 2 species in the gut are quite different, with *Bacteroides* predominantly colonising the small intestine and *Campylobacter* generally favoring the cecum (Newell and Fearnley, [@bib28]; Callaway and Rickes, [@bib10]).

As a consequence of these improvements in nutrient absorption and reductions in pathogen burden in the gut, this study found a beneficial effect of probiotic and enzyme supplementation on growth performance of the birds, in line with previous findings (Amerah et al., [@bib3]; Wealleans et al., [@bib41]). In this study the combination of DFM+XAP lead to higher final bodyweights compared to XAP or the probiotic alone, but the difference was not significant; Flores et al. ([@bib18]) reported an improvement in FCR as well as reduced foot-pad lesion score and energy efficiency in DFM+XAP supplemented birds, but no effect on feed intake or BWG, while Wealleans et al. ([@bib42]) found that performance improvements were greater in birds subjected to a coccidiosis vaccine program, rather than those raised with ionophores.

In conclusion, supplementation of a corn-soybean meal-based broiler diet with a combination of xylanase, amylase, and protease improved FI and BWG, while supplementation with xylanase and amylase alone did not. Both resulted in improvements in the ileal digestibility of fat, starch and energy, as well as in the total tract flow of soluble arabinose and a reduction in cecal populations of *Bacteroides* and *Campylobacter* species. Effects of XAP were generally greater in magnitude then effects of XA; this may be due to both independent and interactive effects of protease and NSP-hydrolyzing enzymes in digesting anti-nutritive NSP and in unlocking the complex protein-fiber matrices contained in the cell walls of the grains, as demonstrated by Romero et al. ([@bib35]). When XA or XAP were fed in combination with a multi-strain *Bacillus* probiotic, beneficial effects on growth performance, digestibility of nutrients and energy, NSP flow, and levels of potentially pathogenic *Campylobacter* species in the cecum were observed, supporting an emerging body of evidence that the combined actions of enzymes and probiotics may be beneficial in bringing about greater improvements in broiler growth performance than can be achieved by their use in isolation.
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